Skip to main content

Table 4 Unadjusted and adjusted prevalence ratios for use of randomization with industry and non-industry sponsors in eligible HIV/Hepatitis C interventional trials, ClinicalTrials.gov registry, 2007 to 2010 (N = 468)

From: A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design

Sponsor

Prevalence ratio

95% CI

Unadjusted:

1.17

0.94, 1.45

  Industry sponsor

Adjusted:a

1.13

0.82, 1.56

  Industry sponsor

  
  1. aBased on Poisson regression model, adjusted for presence of a data monitoring committee, enrollment size, study phase, number of study sites, inclusion of foreign study sites, exclusion of persons older than age 65, and disease condition.
Back to article page

Trials

ISSN: 1745-6215